Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Immunogenicity and Safety Study of GSK Biologicals' Boostrix™ Vaccine Using a New Syringe Presentation in Healthy Adolescents Aged 10-15 Years

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01362322
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:50.416516+00:00
Published At
2018-08-10T00:00:00+00:00
Record Updated At
2018-08-10
Results Posted At
2018-08-10
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Diphtheria", "Tetanus", "Acellular Pertussis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2018-08-10"
protocolSection.identificationModule.nctId
"NCT01362322"
protocolSection.identificationModule.officialTitle
"Immunogenicity and Safety Study of GSK Biologicals\u0027 Boostrix\u2122 Vaccine Using a New Syringe Presentation in Healthy Adolescents Aged 10-15 Years"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2018-08-10"

Study condition terms

  • Diphtheria (protocolSection.conditionsModule.conditions)
  • Tetanus (protocolSection.conditionsModule.conditions)
  • Acellular Pertussis (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.